Journal Pre-proof J o u r n a l P r e -p r o o f 2 Abstract Irritable bowel syndrome (IBS) is a common gastrointestinal disorder of unknown aetiology for which there is no effective treatment. Although IBS does not increase mortality, it reduces the quality of life and is an economic burden to both the patients themselves and society as a whole. Peptide YY (PYY) is localized in endocrine cells located in the ileum, colon and rectum. The concentration of PYY and the density of PYY cells are decreased in both the colon and rectum but unchanged in the ileum of patients with IBS. The low density of PYY cells in the large intestine may be caused by a decreased number of stem cells and their progeny toward endocrine cells. PYY regulates the intestinal motility, secretion and absorption as well as visceral sensitivity via modulating serotonin release. An abnormality in PYY may therefore contribute to the intestinal dysmotility and visceral hypersensitivity seen in IBS patients. Diet management involving consuming a low-FODMAP diet restores the density of PYY cells in the large intestine and improves abdominal symptoms in patients with IBS. This study shows that diet management appears to be a valuable tool for correcting the PYY abnormalities in the large intestine of IBS patients in the clinic. Highlights  The PYY concentration and the PYY cell density in the large intestine are lower in IBS patients than in healthy subjects.  PYY abnormality in the large intestine might contribute to the intestinal dysmotility and visceral hypersensitivity seen in IBS patients.  Diet management appears to restore the density of intestinal PYY cells in the large intestine of IBS patients. Journal Pre-proof J o u r n a l P r e -p r o o f probably including PYY cells-contain synaptic vesicles and synthetize presynaptic proteins such as synapsin 1, piccolo, bassoon, MUNC13B, RIMS2, latrophilin, and transsynaptic neurexin (Bohorquez et al., 2014; Bohorquez et al., 2015). These cells also synthetize transsynaptic neuroligins 2 and 3, homer 3, and postsynaptic density 95 (Bohorquez et al., Journal Pre-proof 2015)
Introduction
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder worldwide (El-Salhy, 2012 . Moreover, about one-third of patients with ulcerative colitis and about a half of patients with Crohn's disease suffer from IBS while in remission (Ansari et al., 2008; El-Salhy et al., 2014b; El-Salhy et al., 2014d; Isgar et al., 1983; Keohane et al., 2010; Minderhoud et al., 2004; Simren et al., 2002) . In addition, about one-third of patients with coeliac disease suffer from IBS symptoms despite adhering to a gluten-free diet (El-Salhy et al., 2015) . The main symptoms of IBS are recurrent abdominal pain and altered bowel habits (El-Salhy, 2015) . Symptoms vary in both their degree and temporal pattern between patients: from mild to severe, and from daily symptoms to being symptom-free for months (Agreus et al., 1995; Drossman et al., 1993) . IBS is usually diagnosed in patients younger than 50 years (Agreus et al., 1995; Drossman et al., 1993) . The aetiology of IBS is unknown and the condition lacks an effective treatment.
Peptide YY
Since its discovery, peptide YY (PYY) has been found in the endocrine cells that are present between the epithelial cells lining the human ileum, colon and rectum (El-Salhy et al., 1983a; Tatemoto, 1982a; Tatemoto and Mutt, 1980) . PYY cells have also been found in the intestine of several vertebrates (El-Salhy, 1984; El-Salhy et al., 1981; El-Salhy et al., 1982; El-Salhy et al., 1983b) .
Like other enteroendocrine cells, PYY cells have specialized sensory microvilli projecting into the intestinal lumen, and they respond to luminal stimuli such as nutrients by releasing their hormones into the lamina propria (Furness et al., 1999; Furness et al., 2013) . A proteinrich meal reportedly stimulates the release of PYY (El-Salhy et al., 2016) . PYY cells also possess a basal cytoplasmic process that is about 70 μm long and is believed to be involved in their paracrine mode of action (Bohorquez et al., 2011) . This process has been shown to exhibit neuronal axon-like characteristics, and has been named a neuropod (Bohorquez et al., 2011; Bohorquez et al., 2014; Bohorquez et al., 2015) . Enteroendocrine cells-and most J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f 2012c; Vona-Davis and McFadden, 2007) . Furthermore, PYY seems to play an important role in modulating serotonin release from colonic enterochromaffin cells via the endogenous NK2/NK3 cascade system (Kojima et al., 2015) . Serotonin is known to modulate visceral sensitivity and increase gastrointestinal motility and intestinal secretion (El-Salhy et al., 2012b; El-Salhy et al., 2012c) .
PPY also regulates the appetite and food intake (Konturek et al., 2004; Nguyen et al., 2011) .
PYY is released into the circulation in response to meal ingestion (Adrian et al., 1985) , and a reduction in food consumption following the infusion of PYY 3-36 has been reported during test meals. Moreover, the plasma concentration of PYY is low in obese subjects (Batterham et al., 2003; Batterham et al., 2002) . The arcuate nucleus (ARC) in the median eminence is the centre for integrating neurological and blood-borne signals (Cone et al., 2001; Peruzzo et al., 2000; Yu and Kim, 2012) . The ARC lacks a complete blood-brain barrier and the brainstem is close to regions with an incomplete blood-brain barrier (Chaudhri et al., 2006; Yu and Kim, 2012) . This allows both the ARC and brainstem to receive blood-borne signals, such as PYY. PYY 3-36 induces anorexia through binding to receptors Y 2 on the presynaptic terminals of hypothalamic NPY neurons so as to induce the inactivation of these neurons (Michel et al., 1998) .
PYY also affects the appetite via its effect on the ileal brake by inhibiting food intake once nutrients have reached the ileum (Lin et al., 1996a (Lin et al., , 1997 Lin et al., 1996b; Maljaars et al., 2007; Maljaars et al., 2008a; Maljaars et al., 2008b; Ohtani et al., 2001; Pironi et al., 1993; Lin, 1999, 2006) .
Abnormalities in PYY in IBS
The density of PYY cells in the ileum does not differ between IBS patients and healthy (Fishbein et al., 2009; He et al., 2007; Kayahara et al., 2003; Montgomery and Breault, 2008; Potten et al., 2003; Schonhoff et al., 2004a, b) . In patients with congenital malabsorptive diarrhoea and small-intestine allograft rejection, as well as in NEUROG3knockout mice, the reduction in neurogenin 3 seems to result in a low density of enteroendocrine cells (Fishbein et al., 2009; Jenny et al., 2002; Wang et al., 2006) . (Habib et al., 2013) .
PYY role in the pathophysiology of IBS
Based on the current knowledge of the physiological functions of PYY in the gastrointestinal tract and the abnormalities seen in IBS, it can be hypothesized that a low PYY concentration and a low density of PYY cells in the large intestine would lead to a reduction in the amount of PYY released, with this in turn contributing to the dysmotility seen in IBS. Furthermore, since PYY modulates serotonin release, the low PYY concentration could contribute to the visceral hypersensitivity observed in IBS patients.
Clinical implications
Diet management of IBS patients involving consuming a low-FODMAP (fermentable oligo-, di-, and monosaccharides, and polyols) diet was found to restore their PYY cell density to the normal level (Mazzawi et al., 2015) . This change was accompanied by an improvement in abdominal symptoms (Mazzawi et al., 2013) . The interaction between dietary intake and the Journal Pre-proof J o u r n a l P r e -p r o o f 7 enteroendocrine cells is complicated (El-Salhy and Gundersen, 2015; El-Salhy et al., 2019) .
These changes in the density of PYY can be both cause and effect. The low density of PYY cells could be caused by the unsuitable intake of dietary items by Patients with IBS and restoring the density of these cells could be an effect of proper intake of food items (FODMAPs). The diet acts as a substrate for intestinal microbiota (prebiotic) and food items ingested determine the profile of the intestinal microbiota (El-Salhy et al., 2019) . On the other hand, intestinal bacteria ferments the undigested food in the intestinal lumen, which results in fermentation by-products including short-chain fatty acids (SCFA) (El-Salhy et al., 2019) .
SCFA has been found to increase the secretion and upregulate the gene expression of PYY (Karaki et al., 2006; Samuel et al., 2008; Zhou et al., 2008) . These observations suggest that diet management would be the best approach for correcting the PYY abnormalities seen in IBS patients in the clinic.
Conclusion
PYY plays an important role in regulating gastrointestinal motility, secretion and absorption, as well in the appetite. IBS patients have a low PYY concentration and also a low density of PYY cells in the large intestine compared to healthy subjects. These abnormalities seem to contribute to the dysmotility and visceral hypersensitivity seen in IBS patients. A PYY receptor agonist without serious side-effects would be ideal for IBS treatment. However, diet management appears to restore the PYY cell density in the large intestine seems to be the most appropriate approach to correct PYY abnormalities in the clinic. 
